Efficacy of combination therapy using twice-a-day IFN-β followed by IFN-α for chronic hepatitis C.

被引：0
|
作者：
Chikazawa, H [1 ]
Fujiyama, S [1 ]
Tanaka, M [1 ]
Honda, Y [1 ]
Sugi, K [1 ]
Tomita, K [1 ]
机构：
[1] Kumamoto Univ, Sch Med, Dept Internal Med 3, Kumamoto 860, Japan
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2182
引用
收藏
页码：708A / 708A
页数：1
相关论文
共 50 条
  • [41] Polymorphisms in the IFNAR1 gene in patients with chronic hepatitis C:: Outcome of combined IFN-α therapy
    Tena-Tomas, Cristina
    Pedros, Maria Lucia
    de Messias-Reason, Lara J.
    Kremsner, Peter G.
    Kun, Juergen F. J.
    EUROPEAN CYTOKINE NETWORK, 2007, 18 (03) : 136 - 141
  • [42] Twice-a-day versus once-a-day interferon-β therapy in chronic hepatitis C
    Kaito, M
    Yasui-Kawamura, N
    Iwasa, M
    Kobayashi, Y
    Nakagawa, N
    Fujita, N
    Ikoma, J
    Gabazza, EC
    Watanabe, S
    Adachi, Y
    HEPATO-GASTROENTEROLOGY, 2003, 50 (51) : 775 - 778
  • [43] Correlations of IFN-γ-inducible protein-10 with the risk of chronic hepatitis B and the efficacy of interferon therapy in Asians
    Gong, Lu-Lu
    Zhao, Bin-Bin
    Fan, Wen-Feng
    Gong, Lu-Yu
    Chen, Cai-Feng
    Liu, Jing-Jun
    Lu, Xuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (07): : 8367 - 8375
  • [44] IFN-α, IFN-γ, IL-2 combined with TNF-α for predicting efficacy of PD-1 inhibitors combination therapy in patients with solid cancers.
    Xing, Penghui
    Zhang, Jinyan
    Liu, Rongfeng
    Wang, Junyan
    Ma, Ming
    Wang, Lixing
    Jiao, Wenjing
    Shao, Junguo
    Wang, Yuxiang
    He, Hongtao
    Shan, Baoen
    Shi, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-α and ribavirin
    Misery, L
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (08): : 881 - 882
  • [46] HEPATIC IFN-β RESPONSE NEGATIVELY REGULATES STEATOSIS IN CHRONIC HEPATITIS C GENOTYPE 1
    Yuki, Nobukazu
    Matsumoto, Shinji
    Ikura, Yoshihiro
    Kato, Michio
    Yamaguchi, Toshikazu
    HEPATOLOGY, 2010, 52 (04) : 735A - 736A
  • [47] Expression of IFN-γ and its receptor alpha in the peripheral blood of patients with chronic hepatitis C
    张萍
    陈智
    陈峰
    李敏伟
    范骏
    周慧明
    刘继洪
    黄珠
    ChineseMedicalJournal, 2004, (01)
  • [48] IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection
    Sung, Pil Soo
    Hong, Seon-Hui
    Chung, Jae-Hee
    Kim, Sojeong
    Park, Su-Hyung
    Kim, Ho Min
    Yoon, Seung Kew
    Shin, Eui-Cheol
    SCIENTIFIC REPORTS, 2017, 7
  • [49] Effect of 12 month αIFN and Ribavirin combination therapy in chronic hepatitis C unresponsive to αIFN
    Bellobuono, A
    Tempini, S
    Grimoldi, D
    Idéo, GM
    Mondazzi, L
    Brasca, P
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [50] B cell function impacts the efficacy of IFN-β therapy in EAE
    Agasing, Agnieshka M.
    Gawde, Saurabh
    Kumar, Gaurav
    Turner, Emma
    Axtell, Robert C.
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 338
12345